Dosimetric consideration of individual 125I source strength measurement and a large-scale comparison of that measured with a nominal value in permanent prostate implant brachytherapy
Tóm tắt
We investigated the difference between measured and manufacturer's nominal source strength in a large sample of a single model of 125I seeds. Physical characteristics of single seed measurement by the well-type ionization chamber were also investigated to provide dosimetric data. A well-type ionization chamber with a single seed holder was used to measure source strength of all 1935 125I seeds implanted in the initial 28 patients in our hospital. Physical characteristics including linearity of readings for different integral time intervals, reproducibility, isotropy, and axial positional sensitivity were assessed. To calculate the source strength, the integral charge during 30 s was measured and converted to air kerma strength. The nominal activity stated by the manufacturer was compared with the measured value. Linearity, reproducibility, and isotropy of the well-type ionization chamber were within 0.2%. Measured source strength was on average 2.1% (range −7.6% to +7.2%), lower than the nominal value. Standard deviation of all measured seeds was 2.0%. The maximum difference between the measured and the manufacturer's nominal source strength in each patient was −3.7%. The standard deviation averaged 1.6%. The nominal source strength of the 125I seeds agreed well with the measured value. Our study can be helpful as guidance for individual 125I seed source strength measurement.
Tài liệu tham khảo
PC Lee SJ Starr K Zuhlke BJ Moran (1999) ArticleTitleComparison of a proposed five-seed assay method with the single-seed and batch assay methods for I-125 seeds in ultrasound-guided prostate implants Radiat Oncol Invest 7 374–81 Occurrence Handle10.1002/(SICI)1520-6823(1999)7:6<374::AID-ROI8>3.0.CO;2-V Occurrence Handle1:STN:280:DC%2BD3c7gs1yktQ%3D%3D
DE Mellenberg RW Kline (1995) ArticleTitleVerification of manufacturer-supplied 125I and 103Pd air-kerma strengths Med Phys 22 1495–7 Occurrence Handle8531880 Occurrence Handle10.1118/1.597625 Occurrence Handle1:CAS:528:DyaK2MXovVWrs7g%3D
LA DeWerd (1997) Brachytherapy dosimetric assessment: source calibration B Thomadsen (Eds) Categorical course in brachytherapy physics syllabus Radiological Society of North America Oak Brook, IL 143–53
WF Hanson RJ Shalek P Kennedy (1991) Dosimetry quality assurance in the U.S. from the experience of the Radiological Physics Center G Starkschall J Horton (Eds) Proceedings of an American College of Medical Physics Symposium: quality assurance in radiotherapy physics Medical Physics Publishing Madison, WI 255–82
Y Yu L Zuofeng DE Mellenberg DE Mellenberg R Nath MC Schell et al. (1999) ArticleTitlePermanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64 Med Phys 26 2054–76 Occurrence Handle10535622 Occurrence Handle10.1118/1.598721 Occurrence Handle1:STN:280:DC%2BD3c%2FgsVarsg%3D%3D
R Nath L Anderson D Jones C Ling R Loevinger J Williamson et al. (1991) ArticleTitleSpecification of brachytherapy source strength: report of AAPM Task Group No. 32 Med Phys 18 439–48 Occurrence Handle1870487 Occurrence Handle10.1118/1.596691
S Furutani H Ikushima K Ozaki M Oita M Sasaki Y Takegawa et al. (2005) ArticleTitleQuality assurance of I-125 seed permanent implant therapy using a self-color developing reflection-type dosimetry sheet film Radiat Med 23 474–7 Occurrence Handle16485537
LA DeWerd MS Huq IJ Das GS Ibbott WF Hanson TW Slowey et al. (2004) ArticleTitleProcedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine Med Phys 31 675–81 Occurrence Handle15070265 Occurrence Handle10.1118/1.1645681